KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) EPS (Weighted Average and Diluted) (2020 - 2025)

Historic EPS (Weighted Average and Diluted) for Twist Bioscience (TWST) over the last 6 years, with Q4 2025 value amounting to -$0.5.

  • Twist Bioscience's EPS (Weighted Average and Diluted) rose 566.04% to -$0.5 in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.28, marking a year-over-year increase of 6213.02%. This contributed to the annual value of -$1.3 for FY2025, which is 6392.62% up from last year.
  • Latest data reveals that Twist Bioscience reported EPS (Weighted Average and Diluted) of -$0.5 as of Q4 2025, which was up 566.04% from -$0.45 recorded in Q3 2025.
  • Twist Bioscience's 5-year EPS (Weighted Average and Diluted) high stood at $0.33 for Q2 2025, and its period low was -$1.47 during Q2 2024.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.8 (2023), whereas its average is -$0.77.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first tumbled by 4554.46% in 2024, then skyrocketed by 12244.9% in 2025.
  • Twist Bioscience's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.91 in 2021, then rose by 18.68% to -$0.74 in 2022, then decreased by 1.35% to -$0.75 in 2023, then increased by 29.33% to -$0.53 in 2024, then grew by 5.66% to -$0.5 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.5 for Q4 2025, versus -$0.45 for Q3 2025 and $0.33 for Q2 2025.